Table 2.
Model | Overall | P. vivax | P. falciparum | ||||
---|---|---|---|---|---|---|---|
cvAUC | tAUC | cvAUC | tAUC | cvAUC | tAUC | ||
High risk (API > 10) | 2010 | 0.72 | 0.70 | 0.72 | 0.70 | 0.78 | 0.76 |
2011 | 0.80 | 0.76 | 0.80 | 0.75 | 0.86 | 0.74 | |
2012 | 0.82 | 0.80 | 0.82 | 0.80 | 0.84 | 0.81 | |
2013 | 0.84 | 0.80 | 0.83 | 0.80 | 0.87 | 0.80 | |
2014 | 0.83 | 0.82 | 0.82 | 0.82 | 0.85 | 0.84 | |
2015 | 0.82 | 0.79 | 0.82 | 0.79 | 0.87 | 0.85 | |
2016 | 0.82 | 0.80 | 0.82 | 0.81 | 0.87 | 0.84 | |
2017 | 0.82 | — | 0.83 | — | 0.87 | — | |
Very high risk (API > 50) | 2010 | 0.76 | 0.76 | 0.77 | 0.76 | 0.82 | 0.78 |
2011 | 0.85 | 0.81 | 0.84 | 0.80 | 0.88 | 0.81 | |
2012 | 0.85 | 0.82 | 0.85 | 0.81 | 0.87 | 0.76 | |
2013 | 0.86 | 0.80 | 0.86 | 0.80 | 0.89 | 0.84 | |
2014 | 0.84 | 0.84 | 0.84 | 0.83 | 0.89 | 0.83 | |
2015 | 0.85 | 0.83 | 0.85 | 0.82 | 0.89 | 0.86 | |
2016 | 0.84 | 0.83 | 0.84 | 0.83 | 0.88 | 0.83 | |
2017 | 0.85 | — | 0.84 | — | 0.89 | — |
Each cross-validation BRT model built with data of a given year yielded a cross-validated AUC (cvAUC), while its model predictions with testing data of the following year allowed for the estimation of a testing AUC (tAUC).